Convertible note investors in Boston, Massachusetts
Updated 16 Nov 2026
Venture funds
2 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Clean Energy Ventures Clean Energy Ventures backs firms commercializing energy technology and novel company models, with recent companies LineVision and Aepnus Technology. Boston, United States |
Energy, Biotech | Seed, Early stage venture, Late stage venture | 67% | 2 |
| 2 | One Way Ventures One Way Ventures invests in seed-stage immigrant tech founders, with recent investments in Debbie and Preply. Boston, United States |
Hardware, Fintech | Seed, Early stage venture, Late stage venture | 18% | 2 |
Table 1. Convertible note investors in Boston, Massachusetts: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| RA Capital Management | Startup incubator | Boston, United States | •••@racap.com | 617.77••• |
| One Way Ventures | Venture capital firm | Boston, United States | •••@onewayvc.com | (972) ••• |
| Clean Energy Ventures | Venture capital firm | Boston, United States | •••@cleanenergyventures.com | (617) ••• |
| Ground Squirrel Ventures | Micro VC fund | Boston, United States | •••@groundsquirrelventures.com | |
| PAR Capital Management | Venture capital firm | Boston, United States | •••@parcapital.com | (617) ••• |
| The Baupost Group | Hedge fund | Boston, United States | •••@baupost.com | 617-21••• |
| Monashee Investment Management | Hedge fund | Boston, United States | •••@monasheecap.com | |
| EQx Fund | Angel group | Boston, United States | •••@eqxfund.com | 1 508-••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| RA Capital Management | P••• K••• | Managing Partner | p•••@racap.com | In the CSV |
| One Way Ventures | L••• Z••• | General Partner | l•••@onewayvc.com | In the CSV |
| Clean Energy Ventures | D••• G••• | Co-Founder and Managing Partner | d•••@cleanenergyventures.com | In the CSV |
| PAR Capital Management | S••• S••• | Managing Partner, Chief Operating Officer and General Counsel | s•••@parcapital.com | In the CSV |
| EQx Fund | J••• K••• | Founder and CEO | j•••@eqxfund.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 11 of the 23 convertible note investors in Boston, Massachusetts have a published email address, 8 a phone number and 19 a website.
- Fidelity has the most recorded investments, 586, 178 of them as lead investor.
- 5 of them are investors in at least one company that closed its most recent round in the last 12 months.
- RA Capital Management is an investor in 9 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- Software is the most common sector across their 137 portfolio companies (54%).
- Early stage venture is the most common investment stage, recorded for 22 of them (96%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Convertible note investors in Boston, Massachusetts
19 of 23, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity | Investment bank | Boston, United States | Health care, Hardware | Zipline International, Tenstorrent, SiMa.ai | 7 | 586 | 178 | 285 | +1-866••• | In the CSV | |
| 2 | RA Capital Management | Startup incubator, Private equity firm | Boston, United States | Health care, Biotech | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics | 9 | 544 | 183 | 243 | •••@racap.com | 617.77••• | In the CSV |
| 3 | One Way Ventures | Venture capital firm | Boston, United States | Hardware, Fintech | Debbie, Preply | 2 | 108 | 19 | 12 | •••@onewayvc.com | (972) ••• | In the CSV |
| 4 | Clean Energy Ventures | Venture capital firm | Boston, United States | Energy, Biotech | LineVision, Aepnus Technology | 2 | 66 | 44 | 2 | •••@cleanenergyventures.com | (617) ••• | In the CSV |
| 5 | Ground Squirrel Ventures | Micro VC fund | Boston, United States | Fintech | Trove, Appload, GladeFinance | 62 | 5 | 1 | •••@groundsquirrelventures.com | In the CSV | ||
| 6 | PAR Capital Management | Venture capital firm | Boston, United States | Software | Journera, Routehappy | 39 | 9 | 11 | •••@parcapital.com | (617) ••• | In the CSV | |
| 7 | The Baupost Group | Hedge fund | Boston, United States | Commerce | Just Eat Takeaway.com | 38 | 13 | 20 | •••@baupost.com | 617-21••• | In the CSV | |
| 8 | JFF Ventures | Startup accelerator | Boston, United States | Education, Fintech | Besolo, Upswing, Territorium | 35 | 1 | 8 | In the CSV | |||
| 9 | Monashee Investment Management | Hedge fund | Boston, United States | 30 | 1 | 18 | •••@monasheecap.com | In the CSV | ||||
| 10 | EQx Fund | Angel group, Venture capital firm | Boston, United States | Health care, Biotech | Gelmedix | 1 | 19 | 0 | 1 | •••@eqxfund.com | 1 508-••• | In the CSV |
| 11 | Petri | Startup incubator | Boston, United States | Artificial intelligence, Biotech | New Equilibrium Biosciences | 10 | 1 | 0 | In the CSV | |||
| 12 | FoundersEdge | Micro VC fund, Venture capital firm | Boston, United States | 8 | 0 | 0 | •••@foundersedge.com | In the CSV | ||||
| 13 | Raza Shaikh | Angel investor | Boston, United States | Health care | Luminate Health | 8 | 0 | 5 | In the CSV | |||
| 14 | Mount Nebo Capital | Private equity firm, Secondary purchaser | Boston, United States | Commerce | Carbon6 | 7 | 0 | 2 | •••@mountnebo.io | In the CSV | ||
| 15 | Nobska Point Capital | Angel group, Micro VC fund | Boston, United States | 3 | 0 | 0 | ||||||
| 16 | Hancock Capital Management | Venture capital firm, Venture debt fund | Boston, United States | 0 | 0 | 0 | In the CSV | |||||
| 17 | Health Innovation Capital | Venture capital firm | Boston, United States | 0 | 0 | 0 | •••@healthinnovation.vc | 312-26••• | In the CSV | |||
| 18 | Konstantinos Ligris | Boston, United States | 0 | 0 | 0 | In the CSV | ||||||
| 19 | Stephen Oddo | Boston, United States | 0 | 0 | 0 | In the CSV |
Table 2. Convertible note investors in Boston, Massachusetts: the first 19 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | RA Capital Management | Boston, United States | 9 | 47 | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics |
| 2 | Fidelity | Boston, United States | 7 | 40 | Zipline International, Tenstorrent, SiMa.ai |
| 3 | Clean Energy Ventures | Boston, United States | 2 | 4 | LineVision, Aepnus Technology |
| 4 | One Way Ventures | Boston, United States | 2 | 25 | Debbie, Preply |
| 5 | EQx Fund | Boston, United States | 1 | 3 | Gelmedix |
Table 3. Convertible note investors in Boston, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | RA Capital Management | 11 to 50 | 2019 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Fidelity | 1,001 to 5,000 | 2011 |
| Tenstorrent Unicorn | Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. | Artificial intelligence | Santa Clara, United States | Series E | $1.5B | 2026-10-19 | $2.5B | Fidelity | 501 to 1,000 | 2016 |
| SiMa.ai | SiMa.ai develops hardware and software for deploying physical AI applications at the edge. | Artificial intelligence | San Jose, United States | Series C | $150.0M | 2026-09-28 | $505.0M | Fidelity | 101 to 250 | 2018 |
| LineVision | LineVision provides utilities with monitoring and analytics that improve grid capacity, resilience, and safety. | Artificial intelligence | Boston, United States | Series D | $37.5M | 2026-09-17 | $87.3M | Clean Energy Ventures | 51 to 100 | 2018 |
| Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Boston, United States | Series B | $65.5M | 2026-09-03 | $223.5M | RA Capital Management | 11 to 50 | 2022 |
| Claris Biotherapeutics | Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. | Biotech | Jersey City, United States | Series B | $118.0M | 2026-07-28 | $225.1M | RA Capital Management | 1 to 10 | 2018 |
| Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | London, United Kingdom | Series A | $33.6M | 2026-07-09 | $151.1M | RA Capital Management | 51 to 100 | 2019 |
| Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | San Diego, United States | Series E | $277.0M | 2026-06-09 | $678.0M | Fidelity, RA Capital Management | 251 to 500 | 2017 |
| Anduril Industries Unicorn | Anduril Industries develops autonomous systems for defense and national security applications. | Artificial intelligence | Costa Mesa, United States | Series H | $5.0B | 2026-05-13 | $11.4B | Fidelity | 5,001 to 10,000 | 2017 |
Table 4. Convertible note investors in Boston, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 74 | 54% |
| Health care | 65 | 47% |
| Biotech | 51 | 37% |
| Artificial intelligence | 25 | 18% |
| Hardware | 23 | 17% |
| Fintech | 16 | 12% |
| Commerce | 14 | 10% |
| Education | 11 | 8% |
| Energy | 5 | 4% |
| Cybersecurity | 3 | 2% |
Table 5. Convertible note investors in Boston, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Convertible note investors | 23 | 100% |
| Early stage investors | 22 | 96% |
| Seed investors | 16 | 70% |
| Late stage investors | 12 | 52% |
| Debt investors | 11 | 48% |
| Venture investors | 9 | 39% |
| Private equity investors | 6 | 26% |
| Post IPO investors | 5 | 22% |
Table 6. Convertible note investors in Boston, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 3 | 19% |
| 2010s | 7 | 44% |
| 2000s | 2 | 12% |
| 1990s | 1 | 6% |
| 1980s | 2 | 12% |
| 1940s | 1 | 6% |
Table 7. Convertible note investors in Boston, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include convertible note investors and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 23 investors.
- 11 rows carry an email address and 8 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 19 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 23 rows: 4 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many convertible note investors in Boston, Massachusetts are on the list?
- 23, in the file dated 16 November 2026. 5 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 11 of the 23 carry an email address in the download and 8 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 23 rows, 11 firm email addresses and 8 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 8 of the 11 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.